The Impact of HPV Vaccination on Cervical Cancer in adolescent females - A narrative review

Sep 21, 2026

To prevent cervical cancer, a leading cause of global morbidity and mortality among women, HPV vaccination is presented as a well-established intervention linked to human papillomavirus infection prevention. The review highlights evidence for reduced HPV infections and subsequent cervical lesions, alongside research on vaccine safety to strengthen public trust. It reports a narrative synthesis using PubMed and Google Scholar with only free full-text English studies. Persistent misconceptions and unequal access remain key barriers, underscoring the need for education, equity, and integration into routine immunization schedules.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages8

Reading Time20 min

AccessFree to download

Introduction and Background

Review Findings and Rationale

Vaccination Evidence and Safety

Study Methods and Search Strategy

Public Health Implications and Access

|
Review Article
| | --- | | | | The Impact of HPV Vaccination on Cervical Cancer in adolescent females: A narrative review
Vijay Bhalerao1 , Shashank Gotarkar2 , Komal Muneshwar2
1Department of Community Medicine, Jawaharlal Nehru Medical College, School of Epidemiology and Public Health, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India, 2Department of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India | | AbstrAct
To effectively prevent cervical cancer, a leading cause of global morbidity and mortality among women, widespread adoption of the HPV vaccine has a well‑established link to human papillomavirus (HPV) infection. HPV vaccine must be the vaccine’s effectiveness in reducing HPV infections, and subsequent cervical lesions have been extensively demonstrated, marking a pivotal milestone in public health. Important research highlights the vaccine’s safety profile, allaying worries and promoting trust in its application. By targeting HPV strains responsible for a majority of cervical cancer cases, vaccination emerges as a strategic intervention to curb the burden of this malignancy. The strategy is used to search PubMed and Google Scholar, with only free full‑text and English language study included. However, addressing existing misconceptions and ensuring equitable vaccine access remains imperative. Informed decision making is pivotal, necessitating comprehensive public health initiatives that educate communities about the vaccine’s benefits. Encouragingly, successful vaccination programs in various regions have demonstrated tangible reductions in HPV prevalence and cervical cancer incidence. This review concludes by emphasizing the urgent need for global collaboration to integrate HPV vaccination into routine immunization schedules, thereby fortifying the collective effort to mitigate cervical cancer’s impact. As a cost‑effective, evidence‑based strategy, widespread HPV vaccination stands as a linchpin in the ongoing battle against cervical cancer, promising a healthier future for women worldwide.
Keywords: Cervical cancer, HPV, human papillomavirus, prevention, screening | Introduction and Background Cervical cancer, primarily caused by genital HPV infections, has seen significant advancements in prevention and early detection. Routine gynecological examinations and the treatment of malignant lesions have proven highly effective in preventing squamous cervical cancer, the most common variant. [1] However, their impact on adenocarcinoma is somewhat limited. Address for correspondence: Vijay Bhalerao, Department of Community Medicine, Jawaharlal Nehru Medical College, School of Epidemiology and Public Health, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India. E‑[mail: Vijaybhalerao1997@gmail.com](mail: Vijaybhalerao1997@gmail.com) Received: 14‑02‑2024 Accepted: 03‑06‑2024 Revised: 02‑04‑2024 Published: 18‑11‑2024 | Access this article online | | | --- | --- | | Quick Response Code:
| Website:
[http://journals.lww.com/JFMPC](http://journals.lww.com/JFMPC) | | | DOI:
10.4103/jfmpc.jfmpc_235_24 | Unfortunately, cervical cancer ranks second among cancers leading to death in women, with an estimated 280,000 deaths reported among the approximately 500,000 new cases in recent years. [2] The American Cancer Society (ACS) took a significant step in 2002 by recommending DNA testing, liquid‑based cytology, and human papillomavirus (HPV) testing for the early detection and treatment of cervical cancer. [3] This marked the first time the inclusion of HPV testing in cervical cancer screening guidelines. [3] The accumulation of evidence strongly suggests that cervical cancer necessitates vaginal infection with 1 of the 15 human papillomavirus (HPV) strains. [4] This imperative connection has driven the development of preventive vaccin

FAQs

What is the main focus of the narrative review?

The review focuses on how HPV vaccination affects the risk and burden of cervical cancer in adolescent females, emphasizing prevention of HPV infection and downstream cervical lesions.

Which databases and study constraints were used?

The review uses a search in PubMed and Google Scholar and includes only free full-text studies published in English.

What challenges are identified despite evidence for vaccination?

The review emphasizes the need to address existing misconceptions and ensure equitable vaccine access, alongside public health education for informed decision-making.

Sep 21, 2026

Upload by Genevieve